CCA Industries, Inc. Reports Financial Results for the Quarter and Nine Months ended August 31,2022
CCA Industries announced its financial results for the three and nine months ended August 31, 2022. The company reported a net loss of $114,047 for Q3 2022 compared to a loss of $82,109 in Q3 2021. Net income for the nine months was $139,604, a decline from $273,445 in the previous year, mainly due to a non-cash gain last year from the Paycheck Protection Program. EBITDA was $252,321 for nine months, significantly up from $106,664. Sales of Porcelana were disrupted due to FDA regulations, but online sales increased by 58% in Q3. Future retail distribution is expected for the Neutein product.
- Online sales increased by 58% in Q3 2022 compared to Q3 2021.
- EBITDA for the first nine months increased to $252,321 from $106,664.
- Net loss of $114,047 in Q3 2022 compared to a loss of $82,109 in Q3 2021.
- Net income for the nine months decreased from $273,445 to $139,604.
- Sales of Porcelana were interrupted due to FDA regulations, affecting revenue.
LITTLE FERRY, N.J., Oct. 19, 2022 /PRNewswire/ -- CCA Industries, Inc. (OTC: CAWW), announced today its results for the three and nine months ended August 31,2022. The results can be found on the chart below. The Company also announced that Lance Funston stepped down as Chairman of the Board, effective October 1, 2022, but remains as a director. Brent Funston, who has been a director, was appointed as Chairman by the board. Brent Funston is the son of Lance Funston.
Net loss was
Christopher Dominello, Chief Executive Officer commented, "We have had some extraordinary challenges in the third quarter of fiscal 2022 As we previously disclosed, we were notified in April 2022 that the United States FDA has banned the use of hydroquinone in Porcelana. We immediately stopped shipping the Porcelana products. Our Porcelana products were re-formulated but had an expense to dispose of inventory related to the original product. In addition, Porcelana sales were interrupted as we were not able to have the re-formulated product available until the last week of August 2022. We were notified by a major customer in July 2022 that they were reducing significantly the number of stores carrying our Plus White products. However, our online sales increased
Further information, including the Unaudited Financial Statement for the quarter and nine months ended August 31, 2022, the Audited Financial Statements for the year ended November 30, 2021 and the Quarterly Disclosure Statement filed with the OTC, may be found on the Company's investor web site: www.ccainvestor.com
CCA Industries, Inc. manufactures and markets health and beauty aids, each under its individual brand name. The products include, principally, "Plus White" toothpastes and teeth whiteners, "Bikini Zone" medicated topical and shave gels, "Nutra Nail" nail care treatments, "Porcelana" skin care products, "Scar Zone" scar treatment products, "Sudden Change" anti-aging skin care products, brands, "Hair Off" depilatory products, "Solar Sense" sun care products and "Neutein" brain health supplements which the Company licensed in January 2022.
Statements contained in the news release that are not historical facts are forward looking statements as that term is defined in the Private Securities Litigation Reform Act of 1995. Such forward-looking statements are subject to risks and uncertainties, which would cause actual results to differ materially, from estimated results. No assurance can be given that the results in any forward-looking statement will be achieved and actual results could be affected by one or more factors, which could cause them to differ materially. For these statements, we claim the protection of the safe harbor for forward-looking statements contained in the Private Securities Litigation Reform Act.
CCA INDUSTRIES, INC. | |||
Financial Results (Unaudited) | |||
Three Months Ended | |||
August 31, 2022 | August 31, 2021 | ||
Revenues | $ 3,033,908 | $ 3,440,070 | |
Net Income | $ (114,047) | $ (82,109) | |
Earnings Per Share: | |||
Basic | $ (0.02) | $ (0.01) | |
Diluted | $ (0.02) | $ (0.01) | |
Weighted Average Common Shares Outstanding: | |||
Basic | 7,561,684 | 7,546,847 | |
Diluted | 7,561,684 | 7,546,847 | |
ADJUSTED EBITDA * | $ (139,391) | $ (91,292) | |
* Earnings before interest, taxes, depreciation and amortization | |||
Reconciliation of Net Income to EBITDA: | |||
Net Income | $ (114,047) | $ (82,109) | |
Provision for income taxes | (47,197) | (34,306) | |
Interest expense | 20,101 | 20,190 | |
Depreciation and Amortization | 1,753 | 4,933 | |
EBITDA | $ (139,390) | $ (91,292) | |
Nine Months Ended | |||
August 31, 2022 | August 31, 2021 | ||
Revenues | $ 10,371,394 | $ 10,721,510 | |
Net Income | $ 139,604 | $ 273,445 | |
Earnings Per Share: | |||
Basic | $ 0.02 | $ 0.04 | |
Diluted | $ 0.02 | $ 0.04 | |
Weighted Average Common Shares Outstanding: | |||
Basic | 7,561,684 | 7,543,235 | |
Diluted | 7,592,160 | 7,588,203 | |
ADJUSTED EBITDA * | $ 252,321 | $ 106,664 | |
* Earnings before interest, taxes, depreciation, amortization and gain on debt extinguishment | |||
Reconciliation of Net Income to EBITDA: | |||
Net Income | $ 139,604 | $ 273,445 | |
Provision for income taxes | 59,972 | 43,452 | |
Interest expense | 44,368 | 88,328 | |
Depreciation and Amortization | 8,377 | 17,839 | |
EBITDA | $ 252,321 | $ 423,064 | |
Gain on extinguishment of debt | - | (316,400) | |
ADJUSTED EBITDA | $ 252,321 | $ 106,664 | |
View original content:https://www.prnewswire.com/news-releases/cca-industries-inc-reports-financial-results-for-the-quarter-and-nine-months-ended-august-31-2022--301654204.html
SOURCE CCA Industries, Inc.
FAQ
What were CCA Industries' Q3 2022 financial results?
How did CCA Industries' net income change for the nine months ended August 31, 2022?
What impact did FDA regulations have on CCA Industries' sales?
What was the EBITDA for CCA Industries in the first nine months of fiscal 2022?